OTV is a venture capital firm specializing in digital health investments, focusing on mid-growth stage startups that aim to make a significant impact on global health. Founded in 2015, OTV has collectively generated over $4 billion in exit revenue over the last 10 years. The firm's portfolio includes companies such as TytoCare, Lemonaid Health, Emedgene, Scopio, and Donisi Health.

OTV's mission is to identify and support entrepreneurs with innovative, disruptive ideas in the digital health arena, enabling them to build successful, impactful companies. The firm has offices in New York, USA, and Tel Aviv, Israel, and has expanded into the Asia Pacific region with a new office in Shanghai, China.